Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study

Abstract Objectives We examined the impact of liver cirrhosis on the risk of thromboembolic events and bleeding complications in patients with atrial fibrillation or flutter (AFF). Methods This population‐based cohort study used data from Danish health registries. We identified all patients with a f...

Full description

Bibliographic Details
Main Authors: Emil B.Riahi, Kasper Adelborg, Lars Pedersen, Søren R. Kristensen, Anette T. Hansen, Henrik T. Sørensen
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:https://doi.org/10.1002/rth2.12668
_version_ 1797712327152238592
author Emil B.Riahi
Kasper Adelborg
Lars Pedersen
Søren R. Kristensen
Anette T. Hansen
Henrik T. Sørensen
author_facet Emil B.Riahi
Kasper Adelborg
Lars Pedersen
Søren R. Kristensen
Anette T. Hansen
Henrik T. Sørensen
author_sort Emil B.Riahi
collection DOAJ
description Abstract Objectives We examined the impact of liver cirrhosis on the risk of thromboembolic events and bleeding complications in patients with atrial fibrillation or flutter (AFF). Methods This population‐based cohort study used data from Danish health registries. We identified all patients with a first‐time diagnosis of AFF during 1995 to 2015, and followed them from their AFF diagnosis until the end of 2016. Patients were categorized according to the presence or absence of liver cirrhosis. We computed incidence rates per 1000 person‐years and hazard ratios (HRs) with 95% confidence intervals (CIs) based on Cox regression analyses, adjusting for age, CHA2DS2VASc score, and Charlson Comorbidity Index score. Results We identified 273 225 patients with AFF. Of these, 1463 (0.54%) had liver cirrhosis. During 0 to 5 years of follow‐up, compared to patients without liver cirrhosis, patients with liver cirrhosis had higher incidence rates and hazards of ischemic stroke (29.7 vs 21.6; HR, 1.3; 95% CI, 1.1‐1.6), venous thromboembolism (9.2 vs 5.5; HR, 1.5; 95% CI, 1.2‐2.3), but not myocardial infarction (10.2 vs 11.2; HR, 0.9; 95% CI, 0.7–1.2). Patients with liver cirrhosis also had higher rates of hemorrhagic stroke (5.8 vs 3.3; HR, 1.7; 95% CI, 1.1‐2.6), subdural hemorrhage (5.3 vs 1.6; HR, 3.2; 95% CI, 2.1‐4.9), hemorrhage of the lung or urinary tract (24.6 vs 15.2; HR, 1.6; 95% CI, 1.3–2.0), and gastrointestinal hemorrhage (34.5 vs 10.4; HR, 3.3; 95% CI, 2.7–3.9). Conclusion In patients with AFF, liver cirrhosis was associated with an elevated risk of ischemic stroke, venous thromboembolism, and all evaluated bleeding complications.
first_indexed 2024-03-12T07:20:06Z
format Article
id doaj.art-4985e5995920453ab5fa7afbf985b438
institution Directory Open Access Journal
issn 2475-0379
language English
last_indexed 2024-03-12T07:20:06Z
publishDate 2022-02-01
publisher Elsevier
record_format Article
series Research and Practice in Thrombosis and Haemostasis
spelling doaj.art-4985e5995920453ab5fa7afbf985b4382023-09-02T22:33:20ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792022-02-0162n/an/a10.1002/rth2.12668Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort studyEmil B.Riahi0Kasper Adelborg1Lars Pedersen2Søren R. Kristensen3Anette T. Hansen4Henrik T. Sørensen5Department of Clinical Epidemiology Aarhus University Hospital and Aarhus University Aarhus DenmarkDepartment of Clinical Epidemiology Aarhus University Hospital and Aarhus University Aarhus DenmarkDepartment of Clinical Epidemiology Aarhus University Hospital and Aarhus University Aarhus DenmarkThe Atrial Fibrillation Study Group Aalborg University Hospital Aalborg DenmarkDepartment of Clinical Epidemiology Aarhus University Hospital and Aarhus University Aarhus DenmarkDepartment of Clinical Epidemiology Aarhus University Hospital and Aarhus University Aarhus DenmarkAbstract Objectives We examined the impact of liver cirrhosis on the risk of thromboembolic events and bleeding complications in patients with atrial fibrillation or flutter (AFF). Methods This population‐based cohort study used data from Danish health registries. We identified all patients with a first‐time diagnosis of AFF during 1995 to 2015, and followed them from their AFF diagnosis until the end of 2016. Patients were categorized according to the presence or absence of liver cirrhosis. We computed incidence rates per 1000 person‐years and hazard ratios (HRs) with 95% confidence intervals (CIs) based on Cox regression analyses, adjusting for age, CHA2DS2VASc score, and Charlson Comorbidity Index score. Results We identified 273 225 patients with AFF. Of these, 1463 (0.54%) had liver cirrhosis. During 0 to 5 years of follow‐up, compared to patients without liver cirrhosis, patients with liver cirrhosis had higher incidence rates and hazards of ischemic stroke (29.7 vs 21.6; HR, 1.3; 95% CI, 1.1‐1.6), venous thromboembolism (9.2 vs 5.5; HR, 1.5; 95% CI, 1.2‐2.3), but not myocardial infarction (10.2 vs 11.2; HR, 0.9; 95% CI, 0.7–1.2). Patients with liver cirrhosis also had higher rates of hemorrhagic stroke (5.8 vs 3.3; HR, 1.7; 95% CI, 1.1‐2.6), subdural hemorrhage (5.3 vs 1.6; HR, 3.2; 95% CI, 2.1‐4.9), hemorrhage of the lung or urinary tract (24.6 vs 15.2; HR, 1.6; 95% CI, 1.3–2.0), and gastrointestinal hemorrhage (34.5 vs 10.4; HR, 3.3; 95% CI, 2.7–3.9). Conclusion In patients with AFF, liver cirrhosis was associated with an elevated risk of ischemic stroke, venous thromboembolism, and all evaluated bleeding complications.https://doi.org/10.1002/rth2.12668atrial fibrillationcohort studyhemorrhagic strokeischemic strokeliver cirrhosisvenous thromboembolism
spellingShingle Emil B.Riahi
Kasper Adelborg
Lars Pedersen
Søren R. Kristensen
Anette T. Hansen
Henrik T. Sørensen
Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
Research and Practice in Thrombosis and Haemostasis
atrial fibrillation
cohort study
hemorrhagic stroke
ischemic stroke
liver cirrhosis
venous thromboembolism
title Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
title_full Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
title_fullStr Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
title_full_unstemmed Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
title_short Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
title_sort atrial fibrillation liver cirrhosis thrombosis and bleeding a danish population based cohort study
topic atrial fibrillation
cohort study
hemorrhagic stroke
ischemic stroke
liver cirrhosis
venous thromboembolism
url https://doi.org/10.1002/rth2.12668
work_keys_str_mv AT emilbriahi atrialfibrillationlivercirrhosisthrombosisandbleedingadanishpopulationbasedcohortstudy
AT kasperadelborg atrialfibrillationlivercirrhosisthrombosisandbleedingadanishpopulationbasedcohortstudy
AT larspedersen atrialfibrillationlivercirrhosisthrombosisandbleedingadanishpopulationbasedcohortstudy
AT sørenrkristensen atrialfibrillationlivercirrhosisthrombosisandbleedingadanishpopulationbasedcohortstudy
AT anettethansen atrialfibrillationlivercirrhosisthrombosisandbleedingadanishpopulationbasedcohortstudy
AT henriktsørensen atrialfibrillationlivercirrhosisthrombosisandbleedingadanishpopulationbasedcohortstudy